SDJ
- Product code
- SDJ
- Device name
- Adjunctive Cardiac Amyloidosis Status Indicator
- Device class
- Class 2
- 21 CFR
- 21 CFR 870.2200
- Medical specialty
- Cardiovascular
- Marketing pathway
- 510(K)
- 510(k) clearances (last 3 years)
- 3
- Summaries archived here
- 3 (direct download)
- 510(k) clearances (all years, FDA)
- 3 (all years; only the last 3 years are listed here)
FDA classification definition
The adjunctive cardiac amyloidosis status indicator is a prescription device based on sensor technology or image data to provide information to an interpreting clinician in detecting cardiac amyloidosis. This device is intended for adjunctive use with other physical vital sign parameters and patient information and is not intended to independently direct therapy.
510(k) clearances, last 3 years (3)
| Number | Decision date | Applicant | Device name | Summary |
|---|---|---|---|---|
| K250151 | 2025-06-20 | Eko.Ai Pte Ltd. D/B/A Us2.Ai | Us2.ca | |
| K243866 | 2025-05-21 | InVision Medical Technology Corporatio… | InVision Precision Cardiac Amyloid | |
| K240860 | 2024-11-15 | Ultromics Limited | EchoGo Amyloidosis (1.0) |
Official FDA classification page: SDJ
Classification and pathway per current FDA publications. Data from openFDA (CC0).